Literature DB >> 26715279

MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.

Meizhu Zheng1, Xu Sun2, Yongqing Li1, Wenshu Zuo3.   

Abstract

MicroRNAs are small non-coding RNAs that may also function as oncogenes and tumor suppressor genes, as the abnormal expression of microRNAs is associated with various human tumors. MicroRNA-145 (miR-145) inhibits growth and increases chemo- or radiosensitivity in various cancers. However, the role of miR-145 in breast cancer progression remains unknown. In this study, miR-145 expression level was measured via quantitative real-time PCR in 88 pairs of human breast cancer tissues and adjacent normal tissues and in a panel of human breast cancer cell lines. Cell proliferation and cell migration were assessed by cell viability assay and transwell assay. Western blot was used to verify Rho-associated protein kinase 1 (ROCK1) as a novel target gene of miR-145. Our results showed that miR-145 was frequently downregulated in breast cancer tissues and cell lines. Overexpression of miR-145 in MCF-7 and BT-549 cell lines significantly inhibited cell proliferation, migration, and invasion in vitro. ROCK1 was identified as a target of miR-145, and ectopic expression of miR-145 downregulated ROCK1. Our findings indicate that miR-145 acts as a tumor suppressor and its downregulation in tumor tissues may contribute to the progression of breast cancer through a mechanism involving ROCK1, suggesting miR-145 as a potential new diagnostic and therapeutic target for the treatment of breast cancer.

Entities:  

Keywords:  Breast cancer; MiR-145; Migration; Proliferation; ROCK1

Mesh:

Substances:

Year:  2015        PMID: 26715279     DOI: 10.1007/s13277-015-4722-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  15 in total

1.  Long-term fatigue state in postoperative patients with breast cancer.

Authors:  Xiao-Fang Tan; Fang Xia
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

2.  Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.

Authors:  Xiaoping Zhang; Maoquan Li; Keqiang Zuo; Dan Li; Meng Ye; Lanbao Ding; Haidong Cai; Da Fu; Youben Fan; Zhongwei Lv
Journal:  J Clin Endocrinol Metab       Date:  2013-06-24       Impact factor: 5.958

3.  Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.

Authors:  Dengfeng Li; Wei Jian; Chuankui Wei; Hongming Song; Yifan Gu; Yi Luo; Lin Fang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.

Authors:  Xianzhao Deng; Bo Wu; Ke Xiao; Jie Kang; Jing Xie; Xiaoping Zhang; Youben Fan
Journal:  Cell Physiol Biochem       Date:  2015-01-02

5.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

Review 6.  Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion.

Authors:  Shuh Narumiya; Masahiro Tanji; Toshimasa Ishizaki
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

7.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

8.  miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ.

Authors:  Xiao-Fei Zhang; Ke-ke Li; Lu Gao; Shang-Ze Li; Ke Chen; Jun-Bin Zhang; Di Wang; Rong-Fu Tu; Jin-Xiang Zhang; Kai-Xiong Tao; Guobin Wang; Xiao-Dong Zhang
Journal:  Oncotarget       Date:  2015-02-28

9.  Nuclear expression of snail is an independent negative prognostic factor in human breast cancer.

Authors:  S Muenst; S Däster; E C Obermann; R A Droeser; W P Weber; U von Holzen; F Gao; C Viehl; D Oertli; S D Soysal
Journal:  Dis Markers       Date:  2013-09-22       Impact factor: 3.434

Review 10.  Regulation of microRNAs by epigenetics and their interplay involved in cancer.

Authors:  Xiaolan Liu; Xiaoyan Chen; Xinfang Yu; Yongguang Tao; Ann M Bode; Zigang Dong; Ya Cao
Journal:  J Exp Clin Cancer Res       Date:  2013-11-22
View more
  23 in total

1.  Integrative analysis of miRNA and mRNA paired expression profiling of primary fibroblast derived from diabetic foot ulcers reveals multiple impaired cellular functions.

Authors:  Liang Liang; Rivka C Stone; Olivera Stojadinovic; Horacio Ramirez; Irena Pastar; Anna G Maione; Avi Smith; Vanessa Yanez; Aristides Veves; Robert S Kirsner; Jonathan A Garlick; Marjana Tomic-Canic
Journal:  Wound Repair Regen       Date:  2016-10-04       Impact factor: 3.617

Review 2.  MiR-145: a potential biomarker of cancer migration and invasion.

Authors:  Wen-Xiu Xu; Zhen Liu; Fei Deng; Dan-Dan Wang; Xing-Wang Li; Tian Tian; Jian Zhang; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

3.  Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.

Authors:  Ramzi M Mohammad; Yiwei Li; Irfana Muqbil; Amro Aboukameel; William Senapedis; Erkan Baloglu; Yosef Landesman; Philip A Philip; Asfar S Azmi
Journal:  Small GTPases       Date:  2017-06-23

4.  microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer.

Authors:  Sharon Wang; Jeff C Liu; YoungJun Ju; Giovanna Pellecchia; Veronique Voisin; Dong-Yu Wang; Rajwinder Leha L; Yaacov Ben-David; Gary D Bader; Eldad Zacksenhaus
Journal:  JCI Insight       Date:  2017-08-03

Review 5.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

Review 6.  Emerging therapeutic targets in esophageal adenocarcinoma.

Authors:  Puja Gaur; Clayton R Hunt; Tej K Pandita
Journal:  Oncotarget       Date:  2016-07-26

7.  MicroRNA-340 inhibits invasion and metastasis by downregulating ROCK1 in breast cancer cells.

Authors:  Niraj Maskey; Dengfeng Li; Hui Xu; Hongming Song; Chenyang Wu; Kaiyao Hua; Jialu Song; Lin Fang
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

8.  Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer.

Authors:  Hu Wei; Chen Wen-Ming; Jiao Jun-Bo
Journal:  J Int Med Res       Date:  2017-05-23       Impact factor: 1.671

9.  Downregulation of miR-145 is associated with perineural invasion in penile carcinoma.

Authors:  Jaqueline Diniz Pinho; Gyl Eanes Barros Silva; Antonio Augusto Lima Teixeira Júnior; Marta Regina de Castro Belfort; Juliana Melo Macedo Mendes; José de Ribamar Rodrigues Calixto; Leudivan Ribeiro Nogueira; Rommel Rodriguez Burbano; André Salim Khayat
Journal:  Transl Androl Urol       Date:  2021-05

10.  Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis.

Authors:  Mohsen Sheykhhasan; Naser Kalhor; Azar Sheikholeslami; Masoumeh Dolati; Elaheh Amini; Hoda Fazaeli
Journal:  Biomed Res Int       Date:  2021-06-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.